2

Role of neuronal VEGF signaling in the prefrontal cortex in the rapid antidepressant effects of ketamine
Satoshi Deyama, Eunyoung Bang, Eric S. Wohleb, Xiao-Yuan Li, Taro Kato, Danielle Gerhard, Sophie Dutheil, Jason M. Dwyer, Seth R. Taylor, Marina Picciotto, Ronald S. Duman
Reshaping the depressed brain: A focus on synaptic health
Danielle Gerhard, David A. Ross
Predicting barriers to treatment for depression in a U.S. national sample: a cross-sectional, proof-of-concept study
Adam M. Chekroud, David Foster, Amanda B. Zheutlin, Danielle Gerhard, Brita Roy, Nikolaos Koutsouleris, Abhishek Chandra, Michelle Degli Esposti, Girish Subramanyan, Ralitza Gueorguieva, Martin Paulus, John H. Krystal
Sex-specific molecular changes in depression
Danielle Gerhard, Ronald S. Duman
Rapid-acting antidepressants: mechanistic insights and future directions
Danielle Gerhard, Ronald S. Duman
Cacna1c in the prefrontal cortex regulates depression-related behaviors via REDD1
Zeeba D. Kabir, Anni S. Lee, Caitlin E. Burgdorf, Delaney K. Fischer, Aditi M. Rajadhyaksha, Ethan Mok, Bryant Rizzo, Richard C. Rice, Kamalpreet Singh, Kristie T. Ota, Danielle Gerhard, Kathryn C. Schierberl, Michael J. Glass, Ronald S. Duman, Anjali M. Rajadhyaksha
Molecular and cellular mechanisms of rapid-acting antidepressants ketamine and scopolamine
Eric S. Wohleb, Danielle Gerhard, Alex Thomas, Ronald S. Duman
GABA interneurons mediate the rapid antidepressant-like effects of scopolamine
Eric S. Wohleb, Min Wu, Danielle Gerhard, Seth R. Taylor, Marina Picciotto, Meenakshi Alreja, Ronald S. Duman
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity
Danielle Gerhard, Eric S. Wohleb, Ronald S. Duman
A diet enriched with curcumin impairs newly acquired and reactivated fear memories
Melissa S. Monsey, Danielle Gerhard, Lara M. Boyle, Miguel A. Briones, Ma'ayan Seligsohn, Glenn Schafe